Cite
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
MLA
Frau, Roberto, et al. “The 5-Alpha Reductase Inhibitor Finasteride Reduces Dyskinesia in a Rat Model of Parkinson’s Disease.” Experimental Neurology, vol. 291, May 2017, pp. 1–7. EBSCOhost, https://doi.org/10.1016/j.expneurol.2017.01.012.
APA
Frau, R., Savoia, P., Fanni, S., Fiorentini, C., Fidalgo, C., Tronci, E., Stancampiano, R., Meloni, M., Cannas, A., Marrosu, F., Bortolato, M., Devoto, P., Missale, C., & Carta, M. (2017). The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson’s disease. Experimental Neurology, 291, 1–7. https://doi.org/10.1016/j.expneurol.2017.01.012
Chicago
Frau, Roberto, Paola Savoia, Silvia Fanni, Chiara Fiorentini, Camino Fidalgo, Elisabetta Tronci, Roberto Stancampiano, et al. 2017. “The 5-Alpha Reductase Inhibitor Finasteride Reduces Dyskinesia in a Rat Model of Parkinson’s Disease.” Experimental Neurology 291 (May): 1–7. doi:10.1016/j.expneurol.2017.01.012.